NCT06714773View on ClinicalTrials.gov

Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

January 20, 2024

Primary Completion Date

July 20, 2024

Study Completion Date

August 1, 2024

Conditions
Chondrosarcoma, Grade 2
Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06714773 - Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection | Biotech Hunter | Biotech Hunter